Publications 2019


Tianlin He

Implementation of Proteomics in Clinical Trials

Proteomics Clin Appl. 2019 Mar;13(2):e1800198. doi:  10.1002/prca.201800198. Epub 2019 Feb 12.

PMID: 30702805

View Abstract:   Request Reprint

Download PDF


Krochmal M, van Kessel KEM, Zwarthoff EC, Belczacka I, Pejchinovski M, Vlahou A, Mischak H, Frantzi M.

Urinary peptide panel for prognostic assessment of bladder cancer relapse.

Sci Rep. 2019 May 21;9(1):7635. doi: 10.1038/s41598-019-44129-y.

PMID: 31114012

View Abstract:   Request Reprint



Ferreira JP, Verdonschot J, Collier T, Wang P, Pizard A, Bär C, Björkman J, Boccanelli A, Butler J, Clark A, Cleland JG, Delles C, Diez J, Girerd N, González A, Hazebroek M, Huby AC, Jukema W, Latini R, Leenders J, Levy D, Mebazaa A, Mischak H, Pinet F, Rossignol P, Sattar N, Sever P, Staessen JA, Thum T, Vodovar N, Zhang ZY, Heymans S, Zannad F.

Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure.

Circ Heart Fail. 2019 May;12(5):e005897. doi: 10.1161/CIRCHEARTFAILURE.118.005897.

PMID: 31104495

View Abstract:   Request Reprint



Frantzi M, Gomez Gomez E, Blanca Pedregosa A, Valero Rosa J, Latosinska A, Culig Z, Merseburger AS, Luque RM, Requena Tapia MJ, Mischak H, Carrasco Valiente J.

CE-MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer.

Br J Cancer. 2019 May 16. doi: 10.1038/s41416-019-0472-z. [Epub ahead of print]

PMID: 31092909

View Abstract:   Request Reprint



Schanstra JP, Luong TT, Makridakis M, Van Linthout S, Lygirou V, Latosinska A, Alesutan I, Boehme B, Schelski N, Von Lewinski D, Mullen W, Nicklin S, Delles C, Feuillet G, Denis C, Lang F, Pieske B, Bascands JL, Mischak H, Saulnier-Blache JS, Voelkl J, Vlahou A, Klein J.

Systems biology identifies cytosolic PLA2 as a target in vascular calcification treatment.

JCI Insight. 2019 May 16;4(10). pii: 125638. doi: 10.1172/jci.insight.125638. eCollection 2019 May 16.

PMID: 31092728

View Abstract:   Request Reprint



Latosinska A, Siwy J, Mischak H, Frantzi M.

Peptidomics and Proteomics based on CE-MS as a robust tool in clinical application: The past, the present, and the future.

Electrophoresis. 2019 May 3. doi: 10.1002/elps.201900091. [Epub ahead of print]

PMID: 31054149

View Abstract:   Request Reprint



Mokou M, Klein J, Makridakis M, Bitsika V, Bascands JL, Saulnier-Blache JS, Mullen W, Sacherer M, Zoidakis J, Pieske B, Mischak H, Roubelakis MG, Schanstra JP, Vlahou A.

Proteomics based identification of KDM5 histone demethylases associated with cardiovascular disease.

EBioMedicine. 2019 Feb 27. pii: S2352-3964(19)30118-5. doi: 10.1016/j.ebiom.2019.02.040. [Epub ahead of print]

PMID: 30826357

View Abstract:   Request Reprint



Ricci P, Magalhães P, Krochmal M, Pejchinovski M, Daina E, Caruso MR, Goea L, Belczacka I, Remuzzi G, Umbhauer M, Drube J, Pape L, Mischak H, Decramer S, Schaefer F, Schanstra JP, Cereghini S, Zürbig P.

Urinary proteome signature of Renal Cysts and Diabetes syndrome in children.

Sci Rep. 2019 Feb 18;9(1):2225. doi: 10.1038/s41598-019-38713-5.

PMID: 30778115

View Abstract:   Request Reprint



Frantzi M, Mischak H, Latosinska A.

Clinical proteomics on the path towards implementation: first promises delivered.

Proteomics Clin Appl. 2019 Feb 14:e1800094. doi: 10.1002/prca.201800094. [Epub ahead of print] No abstract available.

PMID: 30767399

View Abstract:   Request Reprint



Frantzi M, Latosinska A, Mischak H.

Proteomics in Drug Development: the Dawn of a New Era?

Proteomics Clin Appl. 2019 Feb 5:e1800087. doi: 10.1002/prca.201800087. [Epub ahead of print] Review.

PMID: 30724014

View Abstract:   Request Reprint



Marx D, Metzger J, Olagne J, Belczacka I, Faguer S, Colombat M, Husi H, Mullen W, Gwinner W, Caillard S.

Proteomics in kidney allograft transplantation - Application of molecular pathway analysis for kidney allograft disease phenotypic biomarker selection.

Proteomics Clin Appl. 2019 Jan 25:e1800091. doi: 10.1002/prca.201800091. [Epub ahead of print] Review.

PMID: 30680934

View Abstract:   Request Reprint



Siwy J, Klein T, Rosler M, von Eynatten M.

Urinary Proteomics as a tool to Identify Kidney Responders to Dipeptidyl Peptidase-4 Inhibition. A Hypothesis-Generating Analysis from the MARLINA-T2D Trial.

Proteomics Clin Appl. 2019 Jan 11:e1800144. doi: 10.1002/prca.201800144. [Epub ahead of print]

PMID: 30632692

View Abstract:   Request Reprint